Table 2. Expression of MMP9, TIMP1 and PPAR-γ of COPD patients with different pulmonary functional impairment.
Analyte | Group I | Group II | Group III | Group IV | F | P |
---|---|---|---|---|---|---|
PPAR-γ (ng/L) | 132.64±20.42 | 128.62±23.62 | 119.11±21.93 | 103.68±27.87 | 3.28 | 0.045 |
TIMP1 (U/L) | 107.85±17.25 | 99.51±16.63 | 86.84±14.53 | 82.15±8.40 | 6.22 | 0.004 |
MMP9 (μg/L) | 16.83±3.34 | 17.16±4.55 | 17.49±8.67 | 25.55±9.87 | 3.69 | 0.031 |
MMP9/TIMP1 | 0.13±0.05 | 0.18±0.07 | 0.21±0.13 | 0.31±0.13 | 3.78 | 0.29 |